HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Investment analysts at HC Wainwright lifted their FY2025 earnings estimates for HIVE Blockchain Technologies in a report issued on Thursday, November 14th. HC Wainwright analyst M. Colonnese now forecasts that the company will post earnings of ($0.46) per share for the year, up from their previous estimate of ($0.48). HC Wainwright has a “Strong-Buy” rating on the stock. HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q4 2025 earnings at ($0.10) EPS and Q4 2026 earnings at $0.04 EPS.
HIV has been the subject of several other research reports. Northland Capmk raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th. Cantor Fitzgerald upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Read More
- Five stocks we like better than HIVE Blockchain Technologies
- Dividend Payout Ratio Calculator
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Pros And Cons Of Monthly Dividend Stocks
- Applied Materials Market Capitulates: Now is the Time to Buy
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
